EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Association between Vascular Abnormalities and Glaucoma—What Comes First?

Xiaosha Wang, Maoren Wang iD, Hanhan Liu, Karl Mercieca, Julia Prinz, Yuan Feng, Verena Prokosch

International Journal of Molecular Sciences · 25.08.2023 · 24 (17) · 13211

DOI: 10.3390/ijms241713211 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.08.2023. Verfasst von Xiaosha Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Glaucoma. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glaucoma is a leading cause of irreversible blindness worldwide. While intraocular pressure (IOP) presents a major risk factor, the underlying pathophysiology still remains largely unclear. The correlation between vascular abnormalities and glaucoma has been deliberated for decades. Evidence for a role played by vascular factors in the pathogenesis of glaucomatous neurodegeneration has already been postulated. In addition, the fact that glaucoma causes both structural and functional changes to retinal blood vessels has been described. This review aims to investigate the published evidence concerning the relationship between vascular abnormalities and glaucoma, and to provide an overview of the “chicken or egg” dilemma in glaucoma. In this study, several biomarkers of glaucoma progression from a vascular perspective, including endothelin-1 (ET-1), nitric oxide, vascular endothelial growth factor (VEGF), and matrix metalloproteinases (MMPs), were identified and subsequently assessed for their potential as pharmacological intervention targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor AGlaucomaHumansIntraocular PressureBlindnessEndothelin-1

Stichwörter der Autor:innen

glaucomaintraocular pressureneurodegenerationvascular abnormalitiesvascular biomarkers

Substanzen

Vascular Endothelial Growth Factor AEndothelin-1

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
  • Department of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Glaucoma Section, University Hospital Eye Clinic, 53127 Bonn, Germany.
  • Faculty of Biology, Medicine and Health, School of Health Sciences, University of Manchester, Manchester M13 9WH, UK.
  • Department of Ophthalmology, RWTH Aachen University, 52074 Aachen, Germany.

ORCID-Profile: Maoren Wang

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Wang, X., Wang, M., Liu, H., Mercieca, K., Prinz, J., Feng, Y., & Prokosch, V. (2023). The Association between Vascular Abnormalities and Glaucoma—What Comes First?. International Journal of Molecular Sciences, 24(17), 13211. https://doi.org/10.3390/ijms241713211

Vancouver

Wang X, Wang M, Liu H, Mercieca K, Prinz J, Feng Y, et al. The Association between Vascular Abnormalities and Glaucoma—What Comes First?. International Journal of Molecular Sciences. 2023;24(17):13211. doi:10.3390/ijms241713211

BibTeX
@article{Wang2023,
  author = {Wang, Xiaosha and Wang, Maoren and Liu, Hanhan and Mercieca, Karl and Prinz, Julia and Feng, Yuan and Prokosch, Verena},
  title = {The Association between Vascular Abnormalities and Glaucoma—What Comes First?},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {17},
  pages = {13211},
  doi = {10.3390/ijms241713211}
}
Kostenlos starten →